Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
11,471,760
-
Share change
-
-650,290
-
Total reported value
-
$615,316,180
-
Put/Call ratio
-
117%
-
Price per share
-
$53.65
-
Number of holders
-
157
-
Value change
-
-$30,846,888
-
Number of buys
-
63
-
Number of sells
-
78
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q2 2016
As of 30 Jun 2016,
Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,471,760 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, THOMPSON SIEGEL & WALMSLEY LLC, BTIM Corp., HealthInvest Partners AB, BlackRock Institutional Trust Company, N.A., AMI ASSET MANAGEMENT CORP, and KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC.
This page lists
157
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.